Psychemedics Corporation (PMDI)
OTCMKTS · Delayed Price · Currency is USD
2.100
0.00 (0.00%)
Oct 20, 2025, 9:30 AM EDT
Psychemedics Market Cap
Psychemedics has a market cap or net worth of $12.85 million as of October 22, 2025. Its market cap has decreased by -3.34% in one year.
Market Cap
12.85M
Enterprise Value
12.60M
Revenue
19.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.10
Market Cap Chart
Since June 15, 1992, Psychemedics's market cap has decreased from 33.72M to 12.85M, a decrease of -61.89%. That is a compound annual growth rate of -2.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 12.85M | -6.06% |
| Dec 31, 2024 | 13.68M | -20.34% |
| Dec 29, 2023 | 17.17M | -37.97% |
| Dec 30, 2022 | 27.69M | -28.84% |
| Dec 31, 2021 | 38.91M | 38.31% |
| Dec 31, 2020 | 28.13M | -44.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Glass House Brands | 663.09M |
| Elite Pharmaceuticals | 636.35M |
| Northwest Biotherapeutics | 340.56M |
| Silence Therapeutics | 339.61M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 326.28M |
| American Oncology Network | 293.21M |